The Surgery of the Thyroid in Pregnancy by M J Lange FRCSEd (London) At the Endocrine Unit, New End Hospital, we do not usually regard pregnancy as a contraindication to thyroidectomy. If surgery is decided on, we prefer to operate between the third and sixth months of pregnancy. These patients conveniently fall into two categories: those with nontoxic goitres, and those with thyrotoxicosis.
Non-toxic Goitres
Those patients with small symptomless lobulated goitres, usually a persistent puberty type of goitre, need no treatment. A little increase in size during pregnancy is not unusual, and it is as well to inform the patient of this. If it is a nodular goitre, small and symptomless, and there is no undue increase in size reported, surveillance only is recommended.
If there are pressure symptomstightness in the throat, feelings of constriction in the neck, dry irritable cough, dysphagia, stridor, &c.thyroidectomy is advised. Large nodular goitres, even though apparently symptomless, are usually referred for surgery as a prophylactic measure.
Non-pregnant patients presenting with a discrete nodule in the thyroid are subjected to radioiodine studies to determine the functional capacity of the nodule. The functionless 'cold' nodule is immediately referred for surgery in view of the high incidence of neoplastic change. However, in the pregnant patient radioactive iodine investigation is contraindicated and it is wisest to recommend surgery in all these cases.
If the goitre has recently increased in size, if there is accompanying local discomfort, voice changes, a suspicious hardness, or if enlarged regional lymph nodes are present, then prompt exploration of the goitre, irrespective of the stage of pregnancy, is indicated. Though no case of malignant goitre was encountered in our series, it is considered that neoplastic changes occurring during pregnancy would be of the more rapidly growing type.
Thyrotoxicosis
In the presence of florid thyrotoxicosis, irrespective of the stage of pregnancy, the cardinal principle is to control the thyrotoxicosis as soon as possible by means of antithyroid drugs. By preference we use carbimazole in a dosage of 10 mg, thrice daily. If there are side-effects to this drug we employ potassium perchlorate. As soon as the thyrotoxicosis comes under control, we decide on definitive treatment. Thus, if the thyrotoxicosis is controlled by the 6th month, Lugol's iodine is added to the carbimazole and two to three weeks later the patient is admitted for thyroidectomy. But if the toxicity is not controlled by the 6th month, surgery is postponed and the antithyroid drug (in increased dosage if necessary) is continued until the toxicity is brought under control and then the dose is gradually reduced. Reduction is continued until a dose is arrived at which is large enough to control the thyrotoxicosis, yet not to induce hypothyroidism. The daily dose of carbimazole may be as low as 2 5 mg or as high as 20 mg.
This regime requires the most meticulous supervisiontoo rapid a reduction in the dosage may result in relapse of the thyrotoxicosis, whilst persevering with the full dose, in spite of toxicity coming under control, will almost certainly result in hypothyroidism. In this event, the foetus may develop, and be born with, a goitre.
When the patient is balanced on a maintenance dose, it is continued throughout the remainder of pregnancy. After parturition the whole question can be reviewed. As a rule these patients come to surgery. It is not unusual for a proportion of them to go into remission as term approaches, so that the antithyroid drug may be stopped for the remainder of the pregnancy.
To bring the thyrotoxic patient under control usually takes six to twelve weeks' treatment with antithyroid drugs. It follows therefore that the pregnant thyrotoxic seen before the 4th or 5th month of pregnancy will usually be treated by detoxication and surgery, whilst those seen for the first time at the 5th or 6th month, will be treated by antithyroid drugs, at first in therapeutic and subsequently in maintenance doses.
In cases of mild thyrotoxicosis, the exhibition of antithyroid drugs is not as a rule necessary, Lugol's iodine for the two to three weeks immediately before surgery being sufficient. These patients, if seen in the last few months of pregnancy, are best treated with antithyroid drugs throughout the remainder of gestation.
The occasional pregnant thyrotoxic, in the younger age group with the more stable temperament and with a small lobulated goitre that responds quickly to anti-thyroid drugs, may be worthy of trial treatment by medical means. This type of patient will occasionally remit on prolonged antithyroid drug treatment.
No special precautions are needed for these cases undergoing operation. They are admitted one or two days before operation. Anaesthesia is induced with Pentothal and maintained with nitrous oxide and oxygen, and perhaps halothane, the anesthetist taking steps to avoid the patient straining and reducing post-operative nausea and vomiting to a minimum. We are perhaps a little more liberal with postoperative sedatives in these patients. Like the non-pregnant patient, these cases are up on the day after operation and are usually discharged 8 to 10 days after operation.
Review
In a recent series of 3,500 consecutive thyroidectomies performed between 1947 and 1959 there were 49 pregnant patients. All were between the ages of 20 and 45, the majority under 30. In most patients at the time of operation, the pregnancy had advanced to between the 12th and 24th weeks. Three were just beyond, and two just under this period. Twenty of the 49 were primi-pare, and together with the para-I patients accounted for nearly 75%. The non-toxic, the mildly toxic and obviously toxic each accounted for approximately one-third of the total. In certain instances, taking into consideration the history, the patient's domestic background and psychological make-up, we concluded that the pregnancy itself might have precipitated the thyrotoxicosis. It was thought that this had occurred in 11 of the 31 toxic patients (Fig 1) . The primiparn and the para-I patients account for 77 % of the toxic cases. Pregnancy as a precipitating factor was not unexpectedly most evident in the primipar.
Follow up: Of the 49 patients, 44 were seen one month after discharge from hospital and found to be fit and well with the pregnancy proceeding normally. Trace has been lost of 4. A further 8 were lost trace of subsequently and the result of parturition in these is not known.
In this series there occurred only one known abortion following the operation.
Conclusion. There appears to be no increased hazard to the pregnant patient undergoing thyroidectomy, provided the thyrotoxicosis has been controlled and operation is undertaken between the 12th and 24th weeks. (1924) introduced the term hyperinsulinism to describe the condition in which symptoms appeared spontaneously similar to those produced by the administration of excess insulin. Gorsuch & Rynearson (1944) suggested that hyperinsulinism should be reserved to describe the entity of insulin overproduction by an islet cell tumour (insulinoma) and it is in this sense that it will be used in the present communication.
Hyperinsulinism is an important cause of neurological disease. Though generally considered to be rare this rarity may be more apparent than real. This report is based upon 16 cases, of which 9 were first recognized within the past two and a half years. Of these 9 patients an islet cell tumour was removed with benefit in 8; the ninth patient refused operation though the diagnosis was not in doubt clinically. One additional patient with symptoms and occasional low blood sugars was operated upon but no tumour was found. The tumour was examined histologically in 13. It was benign in 7, recurrent and multiple in 1, metastatic in 4 and probably malignant in another. Three patients refused operation. One patient with a proven tumour had renal glycosuria and amino-aciduria.
A delay in diagnosis may have far-reaching and disastrous consequences. One young woman of 23, seen ten years ago, died within a year of the onset of symptoms. The true nature of her illness was not suspected until a small, benign l-cell adenoma of the pancreas was found at autopsy.
The failure to consider the possibility of hyperinsulinism as an wtiological factor is responsible for misdiagnosis in most cases. The symptomatology is inconstant from patient to patient; and in the same patient from time to time. It
